Tracy Todd BatchelorMD, MPH
Dr. Batchelor’s primary field of clinical expertise relates to the therapy of malignancies of the central nervous system and neurologic complications of cancers. He has published extensively on the subject and has been a primary investigator on innovative clinical trials, both nationally and internationally. His research relates to the understanding of aberrant angiogenesis and signaling in brain cancers. Dr. Batchelor is the principal investigator of the Dana-Farber/Harvard Cancer Center (DF/HCC) SPORE grant, as well as of the K12 neuro-oncology training fellowship for DF/HCC. In addition, Dr. Batchelor holds R01 funding from the National Cancer Institute (NCI) and he currently serves as the co-chair for the NCI Brain Malignancies Steering Committee. He has held and holds numerous leadership positions within the American Academy of Neurology and the Society for Neuro-Oncology.
Dr. Batchelor received his medical degree from Emory University School of Medicine and a master’s in public health from the Harvard T.H. Chan School of Public Health. He completed his medicine internship, neurology residency and a neuro-oncology fellowship at Yale-New Haven Hospital, Massachusetts General Hospital, and Memorial Sloan-Kettering Cancer Center, respectively.
He has received multiple accolades for his excellence and leadership in the field, including awards from the American Academy of Neurology and the Society for Neuro-Oncology. He was awarded the Raymond D. Adams Award for excellence in mentoring by the MGH in 2018. Dr. Batchelor will be proposed to Harvard Medical School as the next incumbent of the Miriam Sydney Joseph Professorship in Neurology at Harvard Medical School.